Alkermes reports positive data on multiple sclerosis drug
Posted: Wed Feb 11, 2015 5:07 am
Alkermes reports positive data on multiple sclerosis drug ALKS 8700
Alkermes plc has reported positive top-line data from a phase I study on its experimental MS drug, ALKS 8700. ALKS 8700 is a novel monomethyl fumarate (MMF) molecule being developed for the treatment of MS..... Read More - http://www.ms-uk.org/emergingtherapies
Alkermes plc has reported positive top-line data from a phase I study on its experimental MS drug, ALKS 8700. ALKS 8700 is a novel monomethyl fumarate (MMF) molecule being developed for the treatment of MS..... Read More - http://www.ms-uk.org/emergingtherapies